Percutaneous cryoablation in the management of spinal metastases: a comprehensive systematic review and meta-analysis - Takeaways - MDSpire

Percutaneous cryoablation in the management of spinal metastases: a comprehensive systematic review and meta-analysis

  • By

  • Mohammad Sadegh Fallahi

  • S. Farzad Maroufi

  • S. Parmis Maroufi

  • MirHojjat Khorasanizadeh

  • Leonardo José Monteiro de Macêdo Filho

  • Konstantinos Margetis

  • Daipayan Guha

  • Claudio E. Tatsui

  • Alireza Mansouri

  • May 13, 2025

  • 0 min

Share

  • 1

    Percutaneous cryoablation (PCA) effectively destroys spinal metastases by inducing cold-induced cellular damage and apoptosis.

  • 2

    PCA allows real-time monitoring via CT and MRI, enabling precise targeting while preserving adjacent vital organs.

  • 3

    The procedure can be performed as an outpatient without general anesthesia, enhancing its accessibility for patients.

  • 4

    PCA significantly improves pain management by targeting nociceptive pathways, leading to reduced pain scores and opioid dependence.

  • 5

    Challenges remain in optimizing patient selection and treatment protocols for PCA in managing spinal metastatic lesions.

Original Source(s)

Percutaneous cryoablation in the management of spinal metastases: a comprehensive systematic review and meta-analysis

  • by Mohammad Sadegh Fallahi, S. Farzad Maroufi, S. Parmis Maroufi, MirHojjat Khorasanizadeh, Leonardo José Monteiro de Macêdo Filho, Konstantinos Margetis, Daipayan Guha, Claudio E. Tatsui, Alireza Mansouri

  • May 13, 2025

Related Content

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series

Biotech exec Jeremy Levin on the industry’s strategic turning point

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases